APA (7th ed.) Citation

Rahaghi, F. F., Balasubramanian, V. P., Bourge, R. C., Burger, C. D., Chakinala, M. M., Eggert, M. S., . . . Hill, N. S. (2022). Delphi consensus recommendation for optimization of pulmonary hypertension therapy focusing on switching from a phosphodiesterase 5 inhibitor to riociguat. Pulmonary Circulation, 12(2), 1. https://doi.org/10.1002/pul2.12055

Chicago Style (17th ed.) Citation

Rahaghi, Franck F., et al. "Delphi Consensus Recommendation for Optimization of Pulmonary Hypertension Therapy Focusing on Switching from a Phosphodiesterase 5 Inhibitor to Riociguat." Pulmonary Circulation 12, no. 2 (2022): 1. https://doi.org/10.1002/pul2.12055.

MLA (9th ed.) Citation

Rahaghi, Franck F., et al. "Delphi Consensus Recommendation for Optimization of Pulmonary Hypertension Therapy Focusing on Switching from a Phosphodiesterase 5 Inhibitor to Riociguat." Pulmonary Circulation, vol. 12, no. 2, 2022, p. 1, https://doi.org/10.1002/pul2.12055.